prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FINAL DIAGNOSIS: PART 1: BREAST, LEFT AT 2 O'CLOCK, SEED LOCALIZED SEGMENTAL MASTECTOMY (26.95 grams) -. A. INVASIVE DUCTAL CARCINOMA, 11.0 MM (1.1 CM) IN GREATEST DIMENSION (MEASURED. MICROSCOPICALLY), NOTTINGHAM SCORE 7/9 (TUBULES 3, NUCLEAR GRADE 2, MITOTIC ACTIVITY 2),. NOTTINGHAM GRADE 2. B. DUCTAL CARCINOMA IN-SITU (DCIS), SOLID AND CRIBRIFORM TYPES, NUCLEAR GRADE 2 WITH. ASSOCIATED MICROCALCIFICATIONS AND EXTENSION INTO THE LOBULES, ADMIXED AND ADJACENT. TO THE INVASIVE COMPONENT. C. DCIS SPANS AN AREA OF APPROXIMATELY 0.8 CM (8 MM). D. SURGICAL MARGINS ARE NEGATIVE FOR INVASIVE TUMOR; CLOSEST MARGIN IS ANTERIOR AT 0.45 CM. (4.5 MM) (See Part 6 for additional anterior margin). E. SURGICAL MARGINS ARE NEGATIVE FOR DCIS; DUCTAL CARCINOMA IN SITU IS 0.15 CM (1.5 MM) FROM. THE NEAREST LATERAL MARGIN. F. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. G. LOBULAR CARCINOMA IN SITU, CLASSICAL TYPE, NUCLEAR GRADE 1, IS ALSO IDENTIFIED, WITH. PAGETOID EXTENSION INTO DUCTS. H. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE. ATYPICAL DUCTAL HYPERPLASIA. J. ATYPICAL LOBULAR HYPERPLASIA. K. FIBROCYSTIC CHANGE WITH SCLEROSING ADENOSIS. L. THE INVASIVE TUMOR CELLS ARE ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR. WEAKLY POSITIVE, HER-2/NEU NEGATIVE (1+), AS PER PREVIOUS PATHOLOGY REPORT. PART 2: LYMPH NODE, LEFT AXILLA SENTINEL NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODE, LEFT AXILLA SENTINEL NODE #2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: LYMPH NODES, LEFT AXILLA SENTINEL NODE #3, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/2). PART 5: LYMPH NODE, LEFT AXILLA SENTINEL NODE #4, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 6: BREAST, NEW ANTERIOR MARGIN, EXCISION (13.4 grams) -. A. FOCUS OF INVASIVE DUCTAL CARCINOMA, 0.2 CM IN GREATEST DIMENSION, 0.3 CM FROM THE NEW. ANTERIOR MARGIN (See comment). B. ATYPICAL DUCTAL HYPERPLASIA. C. SCLEROSING ADENOSIS. COMMENT: In Part 1, immunohistochemical staining for E-cadherin is focally negative and P120 demonstrates focal strong. cytoplasmic staining. This immunohistochemical staining pattern supports the diagnosis of lobular carcinoma in situ and. atypical lobular hyperplasia. Part 6: The presence of a 0.2 cm focus of invasive ductal carcinoma is confirmed by immunohistochemical stains for p63. and. (see Microscopic Description). The morphologic features of this microscopic focus of carcinoma are similar. to the invasive ductal carcínoma in Part 1. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Block 1E. Antibody/Antigen. E-cadherin. Negative in areas of atypical lobular hyperplasia. P120. Strong positive cytoplasmic staining in areas of atypical lobular. hyperplasia. Utilizing formalin-fixed (8-96 hour range). paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone(s), directed. against the following antigenic target (s), with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. e-cadherin. 36. Lobular Differentiation. p120. 98. Lobular Differentiation. Block 6F. Antibody/Antigen. SMMHC. Negative in area of interest; supports focus of invasive ductal. carcinoma. P63. Negative in area of interest; supports focus of invasive ductal. carcinoma. Utilizing formalin-fixed (8-96 hour range), paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone (s), directed. against the following antigenic target (s), with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENCOR. Myosin. SMMS-1. Myoepithelial cells. p63. 4A4. Myoepithelial cells. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position:2. SIZE OF TUMOR: Maximum dimension invasive component: 11 mm. MULTICENTRICITY/MULTIFOCALTY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 13 mm. TUMOR TYPE (Invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score; 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. DCIS admixed and outside of invasive carcinoma component. Percent of tumor occupied by in situ component: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 4.5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1.5 mm. LYMPH NODES POSITIVE: o. LYMPH NODES EXAMINED: 5. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: ADH, ALH, FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, previously performed, H-score: 290. positive, previously performed, H-score: 5. PROGESTERONE RECEPTORS: HER2/NEU:

expanded version (tokens=2086) : 
 The breast pathology report reveals the following information:
- Histological classification: Luminal A subtype of breast cancer
- Type of cancer: Invasive ductal carcinoma and ductal carcinoma in situ (DCIS)
- Subtype: Solid and cribiform types of DCIS with extension into the lobules.
- Necrosis: No mention of necrosis.
- Tumor infiltrating lymphocytes: The report does not mention any tumor infiltrating lymphocytes.
- Histological grade: Nottingham score 7/9 (tubules 3, nuclear grade 2, mitotic activity 2), Nottingham grade 2.
- Nuclear grade: Nuclear grade 2 for invasive ductal carcinoma and DCIS.
- Lymphovascular invasion: Lymphovascular space invasion is identified.
- Calcification: Malignant zones of calcification are present.
- Receptor status: Estrogen receptor positive, progesterone receptor weakly positive, HER-2/NEU negative (1+), as per previous pathology report.
- Ancillary testing results: Immunohistochemical staining for E-cadherin is focally negative and P120 demonstrates focal strong cytoplasmic staining, supporting the diagnosis of lobular carcinoma in situ and atypical lobular hyperplasia. The presence of a 0.2 cm focus of invasive ductal carcinoma is confirmed by immunohistochemical stains for p63. 

The report also provides information on lymph node involvement, surgical margins, and

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2237) : 
 Breast pathology report indicates Luminal A subtype with invasive ductal carcinoma and solid/cribiform type DCIS. The tumor measures 1.1cm, grade II, with lymphovascular invasion and lobular carcinoma in situ. Estrogen and progesterone receptors are positive, HER-2/NEU is negative with a focus on p63 immunohistochemical stains for invasive ductal carcinoma. Surgical margins are negative for invasive tumor while one of the five lymph nodes removed shows no metastasis.

